Market research
ALSPW.PA Spineway Société Anonyme
PA EUR Healthcare
Latest close
As of 30 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 3M
- P/E ratio
- Not available
- Analyst target
- 0.21
- Dividend yield
- Not available
- Beta
- 0.29
Profile
Instrument facts
- Exchange
- PA
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- ISIN
- FR001400BVK2
- Market cap
- 3M
- P/E ratio
- Not available
- Analyst target
- 0.21
- Dividend yield
- Not available
- Beta
- 0.29
About
About Spineway Société Anonyme
Spineway SA designs, develops, and markets a range of surgical implants for spine in France. The company offers posterior fixation, including posterior osteosynthesis systems and minimal invasive posterior osteosynthesis systems; interbody fusion products, such as lumbar cage twin peaks tlif curved and oblique; motion preservation products; and biomaterials. It also exports its products. The company was incorporated in 2005 and is headquartered in Ecully, France.
Research context
Spineway Société Anonyme appears in PyInvesting’s Paris Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the ALSPW.PA discussion.
5 years, 6 months ago
Spineway Société Anonyme is currently in a long term uptrend where the price is trading 2.7% above its 200 day moving average.
From a valuation standpoint, the stock is 95.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 12.7.
Finally, its free cash flow fell by 1203.7% to $-447K since the same quarter in the previous year.
Based on the above factors, Spineway Société Anonyme gets an overall score of 2/5.